Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis of Organ Rejection”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT01536379
What this trial is testing

Belimumab in the Prevention of Kidney Transplant Rejection

Who this might be right for
Transplantation, Organ
GlaxoSmithKline 30
Not applicableStudy completedNCT00893919
What this trial is testing

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Who this might be right for
Prophylaxis of Organ Rejection
Roxane Laboratories 37
Testing effectiveness (Phase 2)Looking for participantsNCT07053488
What this trial is testing

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Who this might be right for
Liver DiseasesLiver CancerLiver Cirrhosis+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90
Not applicableStudy completedNCT00893958
What this trial is testing

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions

Who this might be right for
Prophylaxis of Organ Rejection
Roxane Laboratories 39
Not applicableStudy completedNCT00893542
What this trial is testing

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions

Who this might be right for
Prophylaxis of Organ Rejection
Roxane Laboratories 37
Testing effectiveness (Phase 2)UnknownNCT01154387
What this trial is testing

Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

Who this might be right for
End Stage Renal DiseaseRenal Transplant
Tolera Therapeutics, Inc 85
Early research (Phase 1)Study completedNCT06090799
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects

Who this might be right for
Prevention of Graft Rejection After Organ Transplantation
Guangdong Hengrui Pharmaceutical Co., Ltd 6
Not applicableStudy completedNCT00894088
What this trial is testing

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted Conditions

Who this might be right for
Prophylaxis of Organ Rejection
Roxane Laboratories 38
Testing effectiveness (Phase 2)Looking for participantsNCT06552169
What this trial is testing

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Who this might be right for
Kidney Transplantation
Singulera Therapeutics Inc. 34